About: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $20.62 (-2.96%)
NAMS NASDAQ NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares share price
NAMS price activity
Last Price
$20.620
Change (24hr)
-0.63 USD (-2.96%)
Volume
234.79K
Volume (4w avg)
-
Open
$21.20
Day Range
$20.62 - $21.20
Previous Close
$21.25
Last Trade
13 Oct, 4:58 pm GMT+0
Delayed
13 Oct, 4:58 pm GMT+0
NAMS price performance
Delayed
13 Oct, 4:58 pm GMT+0
NAMS Market Signals